Rob Holgate, PhD

VP of Research & Innovation at Abzena

Speaker

Rob has over 25 years’ experience in Drug Discovery and early-stage Development. After obtaining his PhD in Molecular Medicine at UCL, he was post-doctoral researcher at The University of York before to Cambridge Antibody Technology where he was a Senior Scientist within Antibody Engineering then Team Leader of the High Throughput Expression team. Rob joined Antitope (now part of Abzena) in 2008 as a Research Manager. He led Abzena’s Discovery and Protein Engineering group overseeing Abzena’s antibody discovery, antibody humanization, protein deimmunisation and bespoke engineering projects for 15 years before being promoted to his current role of VP of Research & Innovation.